Prime Medicine brings 2 presentations to BPI 2026 in Boston. Its sessions focus on analytics for prime editing therapies. One describes platform liquid chromatography assays that characterize multi-component RNA-LNP products, and another uses automation and AI to speed potency assay validation.
| Organization | BPI 2026 Attendance |
|---|---|
Prime Medicine Cambridge, Massachusetts | 1 Director of Automation & Assays · 1 Analytical Development Scientist II |
Biotechnology company developing gene editing therapies based on prime editing, delivered with technologies such as RNA-lipid nanoparticles. | Talk Wed Sep 23 1:00pm–1:45pm From Bench to BLA: Automation and AI-Accelerated Potency Assay Validation Digital Biomanufacturing & AICell & Gene Therapy |
Instantly find 20 buyers from Prime Medicine
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Informa Connect or the BioProcess International Conference & Exhibition. Submit a correction